Compound ID | 1793
BV200
Class: Antivirulence agent
| Spectrum of activity: | Gram-positive |
| Details of activity: | Transcriptional Regulator Inhibitory Compound: inhibits the quorum-sensing target Agr-A in Staphylococcus aureus and thus inhibits toxin production |
| Combined with other compounds: | Yes |
| Description: | Synthetic compound |
| Institute where first reported: | Bioversys AG |
| Year first mentioned: | 2021 |
| Highest developmental phase: | Preclinical |
| Development status: | Active (as of 2022) |
| External links: | |
| Citation: | https://amr-accelerator.eu/wp-content/uploads/2021/07/BioVersys_Presentations_ECCMID_July_6_2021.pdf |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.